Alterations in liver sinusoidal endothelium in a baboon model of type 1 diabetes

Diabetologia

Volumn 50, Issue 9, 2007, Pages 1969-1976

  Jamieson, H A ^a,b,c   Cogger, V C ^a,b   Twigg, S M ^d   McLennan, S V ^d   Warren, A ^a,b   Cheluvappa, R ^a,b   Hilmer, S N ^a,e   Fraser, R ^f   De Cabo, R ^c   Le Couteur, D G ^a,b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c NATIONAL INSTITUTE ON AGING   (United States)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^e ROYAL NORTH SHORE HOSPITAL   (Australia)

^f UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Diabetes mellitus; Electron microscopy; Fenestrations; Liver sinusoidal endothelial cell; LSEC; Papio hamadryas; Stellate cells

Indexed keywords

CAVEOLIN 1; SMOOTH MUSCLE ACTIN; VON WILLEBRAND FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CELL COUNT; CONTROLLED STUDY; ELECTRON MICROSCOPY; ENDOTHELIUM; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER BIOPSY; LIVER SINUSOID; NONHUMAN; POROSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; STELLATE CELL; STREPTOZOCIN DIABETES;

ANIMALS; BIOPSY; BLOOD GLUCOSE; BLOOD PROTEINS; BODY WEIGHT; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HEMOGLOBIN A, GLYCOSYLATED; LIPIDS; LIVER; MICROSCOPY, ELECTRON, SCANNING; PAPIO;

EID: 34547681197     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-007-0739-4     Document Type: Article

References (35)

1. Singleton JR, Smith AG, Russell JW, Feldman EL (2003) Microvascular complications of impaired glucose tolerance. Diabetes 52:2867-2873
2. Fraser R, Dobbs BR, Rogers GW (1995) Lipoproteins and the liver sieve: the role of fenestrated sinusoidal endothelium in lipoprotein metabolism, atherosclerosis, and cirrhosis. Hepatology 21:863-874
3. Le Couteur DG, Fraser R, Hilmer S, Rivory LP, McLean AJ (2005) The hepatic sinusoid in aging and cirrhosis: effects on hepatic substrate disposition and drug clearance. Clin Pharmacokinet 44:187-200
4. Le Couteur DG, Fraser R, Cogger VC, McLean AJ (2002) Hepatic pseudocapillarisation and atherosclerosis in ageing. Lancet 359:1612-1615
5. Le Couteur DG, Cogger VC, Markus AMA et al (2001) Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 33:537-543
6. Cogger VC, Warren A, Fraser R, Ngu M, McLean AJ, Le Couteur DG (2003) Hepatic sinusoidal pseudocapillarization with aging in the non-human primate. Exp Gerontol 38:1101-1107
7. Warren A, Bertolino P, Cogger VC, McLean AJ, Fraser R, Le Couteur DG (2005) Hepatic pseudocapillarization in aged mice. Exp Gerontol 40:807-812
8. McLean AJ, Cogger VC, Chong GC et al (2003) Age-related pseudocapillarization of the human liver. J Pathol 200:112-117
9. Hilmer SN, Cogger VC, Fraser R, McLean AJ, Sullivan D, Le Couteur DG (2005) Age-related changes in the hepatic sinusoidal endothelium impede lipoprotein transfer in the rat. Hepatology 42:1349-1354
10. Mamo JC, Elsegood CL, Umeda Y, Hirano T, Redgrave TG (1993) Effect of probucol on plasma clearance and organ uptake of chylomicrons and VLDLs in normal and diabetic rats. Arterioscler Thromb 13:231-239
11. Battula SB, Fitzsimons O, Moreno S et al (2000) Postprandial apolipoprotein B48- and B100-containing lipoproteins in type 2 diabetes: do statins have a specific effect on triglyceride metabolism? Metabolism 49:1049-1054
12. Adiels M, Olofsson SO, Taskinen MR, Boren J (2006) Diabetic dyslipidaemia. Curr Opin Lipidol 17:238-246
13. Goldberg IJ, Dansky HM (2006) Diabetic vascular disease: an experimental objective. Arterioscler Thromb Vasc Biol 26:1693-1701
14. Heffernan S, Phippard A, Sinclair A et al (1995) A baboon (Papio hamadryas) model of insulin-dependent diabetes. J Med Primatol 24:29-34
15. Rees DA, Alcolado JC (2005) Animal models of diabetes mellitus. Diabet Med 22:359-370
16. Szkudelski T (2001) The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas. Physiol Res 50:537-546
17. Birrell AM, Heffernan SJ, Kirwan P, McLennan S, Gillin AG, Yue DK (2002) The effects of aminoguanidine on renal changes in a baboon model of type 1 diabetes. J Diabetes Complications 16:301-309
18. Heffernan S, James V, Zilkens R et al (1996) Changes of extracellular matrix in a baboon (Papio hamadryas) model of insulin dependent diabetes: studies using electron microscopy and X-ray diffraction techniques. Diabetes Res Clin Pract 34:65-72
19. Hollestelle MJ, Geertzen HG, Straatsburg IH, van Gulik TM, van Mourik JA (2004) Factor VIII expression in liver disease. Thromb Haemost 91:267-275
20. Ogi M, Yokomori H, Oda M et al (2003) Distribution and localization of caveolin-1 in sinusoidal cells in rat liver. Med Electron Microsc 36:33-40
21. Yokomori H, Oda M, Ogi M, Sakai K, Ishii H (2002) Enhanced expression of endothelial nitric oxide synthase and caveolin-1 in human cirrhosis. Liver 22:150-158
22. Bernuau D, Guillot R, Durand AM et al (1982) Ultrastructural aspects of the liver perisinusoidal space in diabetic patients with and without microangiopathy. Diabetes 31:1061-1067
23. Bernuau D, Guillot R, Durand-Schneider AM, Poussier P, Moreau A, Feldmann G (1985) Liver perisinusoidal fibrosis in BB rats with or without overt diabetes. Am J Pathol 120:38-45
24. Jamieson H, Dobbs BR, Day WA, Rogers GWT, Fraser R (2001) The liver sieve in diabetes: are the ultrastructural changes similar to those seen in alcoholism? In: Wisse E, Knook DL, De Zanger R, Arthur MJP (eds) Cells of the hepatic sinusoid, vol 8. Proceedings of the 10th international symposium on cells of the hepatic sinusoid. Kupffer Cell Foundation, Leiden, pp 123-124
25. Latry P, Bioulac-Sage P, Echinard E et al (1987) Perisinusoidal fibrosis and basement membrane-like material in the livers of diabetic patients. Human Pathol 18:775-780
26. Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM (2006) Diabetic hepatosclerosis: diabetic microangiopathy of the liver. Arch Pathol Lab Med 130:27-32
27. Cogger VC, Hilmer S, Sullivan D, Muller M, Fraser R, Le Couteur DG (2006) Surfactants and hyperlipidemia: the liver sieve is a link. Atherosclerosis 189:273-281
28. Friedman SL (2004) Mechanisms of disease: mechanisms of hepatic fibrosis and therapeutic implications. Nat Clin Pract Gastroenterol Hepatol 1:98-105
29. Ceriello A (2006) Controlling oxidative stress as a novel molecular approach to protecting the vascular wall in diabetes. Curr Opin Lipidol 17:510-518
30. Cogger VC, Mross PE, Hosie MJ, Ansselin AD, McLean AJ, Le Couteur DG (2001) The effect of acute oxidative stress on the ultrastructure of the perfused rat liver. Pharmacol Toxicol 89:306-311
31. Cogger VC, Muller M, Fraser R, McLean AJ, Khan J, Le Couteur DG (2004) The effects of oxidative stress on the liver sieve. J Hepatol 41:370-376
32. McCullough AJ (2004) The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis 8:521-533, viii
33. Van Steenbergen W, Lanckmans S (1995) Liver disturbances in obesity and diabetes mellitus. Int J Obes Relat Metab Disord 19(Suppl 3):S27-S36
34. Mauras N, Merimee T, Rogol AD (1991) Function of the growth hormone-insulin-like growth factor I axis in the profoundly growth-retarded diabetic child: evidence for defective target organ responsiveness in the Mauriac syndrome. Metabolism 40:1106-1111
35. Riley P, O'Donohue J, Crook M (2007) A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. J Clin Pathol DOI 10.1136/jcp.2006.044891